SABS Stock Summary and Trading Ideas (Sab Biotherapeutics | NASDAQ:SABS)

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

Sab Biotherapeutics trades on the NASDAQ stock market under the symbol SABS.

As of September 11, 2026, SABS stock price declined to $3.41 with 696,835 million shares trading.

SABS has a beta of 0.89, meaning it tends to be less sensitive to market movements. SABS has a correlation of 0.03 to the broad based SPY ETF.

SABS has a market cap of $310.26 million. This is considered a Small Cap stock.

In the last 3 years, SABS traded as high as $10.50 and as low as $1.00.

The top ETF exchange traded funds that SABS belongs to (by Net Assets): VTI, VXF, VTWO, AVSC, GSSC.

SABS has outperformed the market in the last year with a return of +60.8%, while the SPY ETF gained +17.4%. However, in the most recent history, SABS shares have underperformed the stock market with its stock returning +0.9% in the last 3 month period and -10.0% for the last 2 week period, while SPY has returned +3.9% and -0.7%, respectively.

SABS support price is $3.32 and resistance is $3.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SABS shares will trade within this expected range on the day.